生物技术通报 ›› 2026, Vol. 42 ›› Issue (1): 338-351.doi: 10.13560/j.cnki.biotech.bull.1985.2025-0600

• 研究报告 • 上一篇    下一篇

桦褐孔菌醇通过激活Nrf2/PGC-1α/线粒体自噬防治AFB1诱导的小鼠肝损伤

康恺1(), 杨微2, 李迎春1, 谢为天1, 吴海燕1, 尤育品1, 陈志宝1,3()   

  1. 1.广东海洋大学滨海农业学院,湛江 524088
    2.华南农业大学动物医学院,广州 510642
    3.国家耐盐碱水稻技术创新中心华南分中心,湛江 524088
  • 收稿日期:2025-06-11 出版日期:2026-01-26 发布日期:2026-02-04
  • 通讯作者: 陈志宝,男,教授,研究方向 :分子药理学;E-mail: chenzb@gdou.edu.cn
  • 作者简介:康恺,女,副教授,研究方向 :细胞生物学与病原学;E-mail: kangk@gdou.edu.cn
  • 基金资助:
    广东省创新强校重点项目(2020ZDZX1043);广东海洋大学启动基金(R2006),广东海洋大学滨海农业学院杰出青年基金(BH2025JCQN007)

Inotodiol Prevention of Aflatoxin B1-induced Liver Injury by Activating Nrf2/PGC-/Mitophagy

KANG Kai1(), YANG Wei2, LI Ying-chun1, XIE Wei-tian1, WU Hai-yan1, YOU Yu-pin1, CHEN Zhi-bao1,3()   

  1. 1.College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang 524088
    2.College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642
    3.South China Branch of National Saline-Alkali Tolerant Rice Technology Innovation Center, Zhanjiang 524088
  • Received:2025-06-11 Published:2026-01-26 Online:2026-02-04

摘要:

目的 桦褐孔菌醇(inotodiol, INO)是从药食两用真菌——桦褐孔菌中提取的三萜类化合物,具有抗氧化、抗炎等生物活性。通过体内外试验研究INO对黄曲霉毒素B1(aflatoxin B1, AFB1)肝毒性的保护效果。 方法 利用AFB1建立小鼠肝脏和肝实质细胞(AML12)损伤模型。制作肝组织切片,分析病理学变化,通过ELISA和抗氧化相关检测试剂盒分析肝组织、血清和AML12细胞中抗氧化水平;荧光显微镜观察活性氧(ROS)和线粒体膜电位(MMP),同时应用Western blot和qPCR实验方法检测肝脏和AML12细胞中Nrf2、PGC-1α、线粒体自噬信号通路蛋白表达情况。 结果 AFB1显著上调肝脏和AML12细胞中细胞色素P450酶(CYP450)基因表达,促进谷草转氨酶(AST)和谷丙转氨酶(ALT)的酶活力(P<0.01),INO预处理显著抑制AFB1诱导的上述指标的升高(P<0.01),且INO有效逆转AFB1诱导的抗氧化能力下降和线粒体功能障碍(P<0.01)。信号通路分析表明,INO可显著缓解AFB1诱导的Nrf2、PGC-1α和线粒体自噬信号通路的抑制,最终减轻AFB1引起的氧化损伤,恢复线粒体功能障碍。 结论 INO在体外和体内均能有效抑制AFB1诱导的肝细胞毒性。INO对肝脏的保护作用与激活Nrf2/PGC-1α信号通路和促进线粒体自噬密切相关。

关键词: 桦褐孔菌醇, AFB1, 肝损伤, 氧化应激, 线粒体自噬

Abstract:

Objective Inotodiol (INO), a triterpenoid compound extracted from the fungus Phaeoporus obliquus, a dual-purpose fungus for both medicine and food. It possesses biological activities such as antioxidant and anti-inflammatory properties. The protective effect of INO on the hepatotoxicity of aflatoxin B1 (AFB1) was studied through in vivo and in vitro experiments. Method The mouse liver and Alpha mouse liver 12 cell (AML12) injury model were established using AFB1. Liver tissue sections were prepared to analyze the pathological changes. The antioxidant levels in liver tissues, serum and AML12 cells were analyzed through ELISA and antioxidant-related detection kits. Reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were detected by fluorescence microscopy. The expressions of Nrf2, PGC-1α, and mitophagy signaling pathway proteins in liver and AML12 cells were detected by Western blot and qPCR. Result AFB1 significantly increased the activities of CYP450, AST, and ALT in the liver and AML12 cells (P<0.01). Pretreatment with INO significantly reduced these proteins’ expressions (P<0.01). INO significantly reversed (P<0.01) the decline in antioxidant capacity and mitochondrial dysfunction induced by AFB1. Analysis of Nrf2, PGC-1α and mitophagy signaling pathways revealed that INO significantly alleviated AFB1-induced suppression of these pathways, and ultimately attenuated oxidative damage and restoring mitochondrial dysfunction caused by AFB1. Conclusion INO inhibits AFB1-induced hepatotoxicity both in vitro and in vivo. The protective effect of INO on the liver is closely related to the activation of the Nrf2/PGC-1α signaling pathway and the promotion of mitophagy.

Key words: inotodiol, aflatoxin B1, liver injury, oxidative stress, mitophagy